Return On Assets of Syndax Pharmaceuticals Inc from 30 Sep 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Syndax Pharmaceuticals Inc quarterly and annual Return On Assets in % history and change rate from 30 Sep 2016 to 30 Sep 2025.
  • Syndax Pharmaceuticals Inc Return On Assets for the quarter ending 30 Sep 2025 was -50%, a 14% increase year-over-year.
  • Syndax Pharmaceuticals Inc annual Return On Assets for 2024 was -59%, a 34% decline from 2023.
  • Syndax Pharmaceuticals Inc annual Return On Assets for 2023 was -44%, a 24% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Return On Assets for 2022 was -35%, a 538% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Syndax Pharmaceuticals Inc Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -50% +8.1% +14% 01 Jul 2025 30 Sep 2025
Q2 2025 -56% -4.1% -8% 01 Apr 2025 30 Jun 2025
Q1 2025 -58% -10% -21% 01 Jan 2025 31 Mar 2025
Q4 2024 -59% -15% -34% 01 Oct 2024 31 Dec 2024
Q3 2024 -58% -18% -46% 01 Jul 2024 30 Sep 2024
Q2 2024 -52% -15% -42% 01 Apr 2024 30 Jun 2024
Q1 2024 -48% -13% -36% 01 Jan 2024 31 Mar 2024
Q4 2023 -44% -8.6% -24% 01 Oct 2023 31 Dec 2023
Q3 2023 -39% -36% -1057% 01 Jul 2023 30 Sep 2023
Q2 2023 -37% -37% -17117% 01 Apr 2023 30 Jun 2023
Q1 2023 -36% -40% -890% 01 Jan 2023 31 Mar 2023
Q4 2022 -35% -44% -538% 01 Oct 2022 31 Dec 2022
Q3 2022 -3.4% +30% +90% 01 Jul 2022 30 Sep 2022
Q2 2022 0.22% +36% 01 Apr 2022 30 Jun 2022
Q1 2022 4.5% +40% 01 Jan 2022 31 Mar 2022
Q4 2021 8.1% +46% 01 Oct 2021 31 Dec 2021
Q3 2021 -34% +16% +31% 01 Jul 2021 30 Sep 2021
Q2 2021 -36% +18% +34% 01 Apr 2021 30 Jun 2021
Q1 2021 -36% +33% +48% 01 Jan 2021 31 Mar 2021
Q4 2020 -38% +31% +45% 01 Oct 2020 31 Dec 2020
Q3 2020 -49% +21% +30% 01 Jul 2020 30 Sep 2020
Q2 2020 -54% +17% +24% 01 Apr 2020 30 Jun 2020
Q1 2020 -69% +3% +4.1% 01 Jan 2020 31 Mar 2020
Q4 2019 -69% +4.3% +5.9% 01 Oct 2019 31 Dec 2019
Q3 2019 -70% -5.5% -8.5% 01 Jul 2019 30 Sep 2019
Q2 2019 -71% -12% -21% 01 Apr 2019 30 Jun 2019
Q1 2019 -72% -19% -37% 01 Jan 2019 31 Mar 2019
Q4 2018 -73% -24% -48% 01 Oct 2018 31 Dec 2018
Q3 2018 -65% -20% -43% 01 Jul 2018 30 Sep 2018
Q2 2018 -59% -13% -30% 01 Apr 2018 30 Jun 2018
Q1 2018 -52% -10% -25% 01 Jan 2018 31 Mar 2018
Q4 2017 -49% -13% -36% 01 Oct 2017 31 Dec 2017
Q3 2017 -45% -12% -37% 01 Jul 2017 30 Sep 2017
Q2 2017 -46% 01 Apr 2017 30 Jun 2017
Q1 2017 -42% 01 Jan 2017 31 Mar 2017
Q4 2016 -36% 01 Oct 2016 31 Dec 2016
Q3 2016 -33% 01 Jul 2016 30 Sep 2016

Syndax Pharmaceuticals Inc Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -59% -15% -34% 01 Jan 2024 31 Dec 2024
2023 -44% -8.6% -24% 01 Jan 2023 31 Dec 2023
2022 -35% -44% -538% 01 Jan 2022 31 Dec 2022
2021 8.1% +46% 01 Jan 2021 31 Dec 2021
2020 -38% +31% +45% 01 Jan 2020 31 Dec 2020
2019 -69% +4.3% +5.9% 01 Jan 2019 31 Dec 2019
2018 -73% -24% -48% 01 Jan 2018 31 Dec 2018
2017 -49% -13% -36% 01 Jan 2017 31 Dec 2017
2016 -36% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.